Vivani Medical, Inc. – NASDAQ:VANI

Add to watchlist

$1.24

+0.05

+5.08%

Market closed

Open in about 14 hours

-11.94%

month

-11.94%

quarter

+13.46%

year

Market Cap	68.71M
Enterprise value	N/A

P/E	-2.66
EV/Sales	N/A
EV/EBITDA	0.43
Price/Sales	N/A
Price/Book	0.78
PEG ratio	0.06
EPS	-0.5

Revenue	N/A
EBITDA	-26.24M
Income	-25.37M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Vivani Medical, Inc. (NASDAQ:VANI): Profit margin
Jun 2023	0	-6.52M
Sep 2023	0	-6.78M
Dec 2023	518K	-6.02M	-1163.32%
Mar 2024	0	-6.03M

Vivani Medical Financials Estimate

Q Y

Vivani Medical, Inc. (NASDAQ:VANI): Analyst Estimates
2025	0	-28.47M
2026	0	-30.51M
2027	0	-33.05M
2028	0	-28.47M

Analysts Price target
Financials & Ratios estimates

Vivani Medical, Inc. (NASDAQ:VANI): Debt to assets
Jun 2023	59607000	27.21M	45.65%
Sep 2023	53319000	27.11M	50.85%
Dec 2023	45797000	25.03M	54.67%
Mar 2024	53788000	25.07M	46.62%

Vivani Medical, Inc. (NASDAQ:VANI): Cash Flow
Jun 2023	-5.55M	-44K	7K
Sep 2023	-7.70M	-63K	103K
Dec 2023	-3.48M	-743K	23K
Mar 2024	-4.51M	-182K	13.69M

Vivani Medical alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Vivani Medical, Inc. (NASDAQ:VANI): Employee count
Aug 2023	50
Sep 2023	50
Oct 2023	50
Nov 2023	50
Dec 2023	50
Jan 2024	50
Feb 2024	50
Mar 2024	50
Apr 2024	50
May 2024	44
Jun 2024	36
Jul 2024	36

Vivani Medical
Hedge Funds Holdings Q1 2023

100.00% 0.00%

of VANI is owned by hedge funds

20 -10

hedge funds hold VANI stock

3.19M -1.03M

shares is hold by hedge funds

VANI hedge funds holdings changes

Vivani Medical
Insider Trading

Vivani Medical, Inc. (NASDAQ:VANI): Insider trades (number of shares)
Period	Buy	Sel
Nov 2022	10000	0
Apr 2023	2040494	0
Jun 2023	19000	0
Aug 2023	12795	0
Sep 2023	68155	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	7 Sep 2023	WILLIAMS GREGG director, 10 percent owner: director, 10 percent owner:	Common Stock	33,700	$0.94	$31,678
Purchase	6 Sep 2023	WILLIAMS GREGG director, 10 percent owner: director, 10 percent owner:	Common Stock	14,570	$0.94	$13,696
Purchase	5 Sep 2023	WILLIAMS GREGG director, 10 percent owner: director, 10 percent owner:	Common Stock	4,997	$0.93	$4,647
Purchase	1 Sep 2023	WILLIAMS GREGG director, 10 percent owner: director, 10 percent owner:	Common Stock	10,888	$0.94	$10,235
Purchase	1 Sep 2023	MAKES BRIGID officer: CFO officer: CFO	Common Stock	4,000	$0.95	$3,780
Purchase	31 Aug 2023	WILLIAMS GREGG director, 10 percent owner: director, 10 percent owner:	Common Stock	5,295	$0.92	$4,871
Purchase	17 Aug 2023	DWYER DONALD officer: Chief Business Officer officer: Chief Business Officer	Common Stock	7,500	$1.08	$8,100
Purchase	28 Jun 2023	MAKES BRIGID officer: CFO officer: CFO	Common Stock	3,000	$1.21	$3,630
Purchase	27 Jun 2023	MAKES BRIGID officer: CFO officer: CFO	Common Stock	1,000	$1.24	$1,240
Purchase	22 Jun 2023	DWYER DONALD officer: Chief Business Officer officer: Chief Business Officer	Common Stock	5,000	$1.24	$6,200

VANI insider trading transactions

Vivani Medical
Earnings Call Transcripts

Quarter	Transcript
Q4 2019 19 Mar 2020	Q4 2019 Earnings Call Transcript
Q3 2019 15 Nov 2019	Q3 2019 Earnings Call Transcript
Q2 2019 7 Aug 2019	Q2 2019 Earnings Call Transcript
Q1 2019 16 May 2019	Q1 2019 Earnings Call Transcript

VANI earnings call transcripts

Vivani Medical
Latest News

Friday, 20 December 2024
12:17	Vivani reports start of first human trial of GLP-1 implant, says H.C. Wainwright	https://thefly.com
Thursday, 19 December 2024
08:30	Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia	businesswire.com
Wednesday, 4 December 2024
08:30	Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast	businesswire.com
Thursday, 26 September 2024
08:30	Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia	businesswire.com
Monday, 23 September 2024
08:57	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024	businesswire.com
Wednesday, 28 August 2024
19:10	Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	businesswire.com
Thursday, 13 June 2024
08:00	Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant	businesswire.com
Tuesday, 28 May 2024
08:00	Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant	businesswire.com
Monday, 13 May 2024
20:52	VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024	InvestorPlace
Wednesday, 6 March 2024
06:14	Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant	MarketBeat
Wednesday, 28 February 2024
13:59	Why Is Vivani Medical (VANI) Stock Up 300% Today?	InvestorPlace
Monday, 16 October 2023
06:00	Vivani Medical to Present at BIO Investor Forum	Business Wire
Tuesday, 5 September 2023
06:00	Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10	Business Wire
Wednesday, 14 June 2023
06:00	Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest	Business Wire

Ideas & Opinions

Seeking Alpha 20 May 2025

I Missed The Quantum Rally - I Won't Miss The Next One

Frequently Asked Questions (FAQ)

What's the price of Vivani Medical stock today?

One share of Vivani Medical stock can currently be purchased for approximately $1.24.
When is Vivani Medical's next earnings date?

Unfortunately, Vivani Medical's (VANI) next earnings date is currently unknown.
Does Vivani Medical pay dividends?

No, Vivani Medical does not pay dividends.
How much money does Vivani Medical make?

Vivani Medical has a market capitalization of 68.71M.
What is Vivani Medical's stock symbol?

Vivani Medical, Inc. is traded on the NASDAQ under the ticker symbol "VANI".
What is Vivani Medical's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Vivani Medical?

Shares of Vivani Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Vivani Medical have?

As Jul 2024, Vivani Medical employs 36 workers, which is 28% less then previous quarter.
When Vivani Medical went public?

Vivani Medical, Inc. is publicly traded company for more then 10 years since IPO on 19 Nov 2014.
What is Vivani Medical's official website?

The official website for Vivani Medical is vivani.com.
Where are Vivani Medical's headquarters?

Vivani Medical is headquartered at 5858 Horton Street, EmeryVille, CA.
How can i contact Vivani Medical?

Vivani Medical's mailing address is 5858 Horton Street, EmeryVille, CA and company can be reached via phone at +81 88335000.

Vivani Medical, Inc.

vivani.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Devices

Sector:

Healthcare

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

+81 88335000

5858 Horton Street
EmeryVille, CA 94608

CIK: 0001266806
ISIN: US92854B1098
CUSIP: 92854B109